FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
21/06/2025
Voltar para busca
Dado oficial do USPTO
PXB-SHIZUKU
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
25/07/2023
Data de registro
17/12/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/12/2024
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
JP
Examinador
SEVERSON, JUSTIN
Unidade examinadora
M20
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
PhoenixBio Co., Ltd.
Representantes
Jeffrey H. Handelsman Greenblum & Bernstein, P.L.C.
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in industry and science; biological preparationsother than for medical or veterinary purposes; cells for scientific and research use; cells for scientific or research useother than for medical or veterinary purposes; cell culture medium for scientific or research useother than for medical or veterinary use; cell culture conditioned medium for scientific or research useother than for medical or veterinary purposes; supernatant of cell culture medium for scientific or research useother than for medical or veterinary purposes; supernatant fluid of cell culture medium for scientific or research useother than for medical or veterinary purposes
Classe 5
Pharmaceutical preparations for treatment of diabetes mellitusliver disease treatmentsurgical treatmentneurological disease treatmentdyslipidemia treatmenttreatment of blood coagulation disorderstreatment of metabolic disorders of iron and coppertreatment of congenital metabolic disorderstreatment of trace element deficiencytreatment of infectious diseases for use in regenerative medicine; medicines for treatment of diabetes mellitusliver disease treatmentsurgical treatmentneurological disease treatmentdyslipidemia treatmenttreatment of blood coagulation disorderstreatment of metabolic disorders of iron and coppertreatment of congenital metabolic disorderstreatment of trace element deficiencytreatment of infectious diseases for use in regenerative medicine for human purposes; medicines for treatment of diabetes mellitusliver disease treatmentsurgical treatmentneurological disease treatmentdyslipidemia treatmenttreatment of blood coagulation disorderstreatment of metabolic disorders of iron and coppertreatment of congenital metabolic disorderstreatment of trace element deficiencytreatment of infectious diseases for use in regenerative medicine for veterinary purposes; cells for medical or veterinary purposes; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; cell culture medium for medical and veterinary purposes; cell culture conditioned medium for medical and veterinary purposes; supernatant of cell culture medium for medical and veterinary purposes; supernatant fluid of cell culture medium for medical and veterinary purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
28/05/2025
FIMP
FINAL DISPOSITION PROCESSED
28/05/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
25/04/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
17/03/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/03/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/02/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/02/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
17/12/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
17/12/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/10/2024
PUBO
PUBLISHED FOR OPPOSITION
15/10/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/09/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/09/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/08/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/08/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
19/08/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
29/05/2024
GNFR
FINAL REFUSAL E-MAILED
29/05/2024
CNFR
FINAL REFUSAL WRITTEN
29/05/2024
RFNT
REFUSAL PROCESSED BY IB
08/05/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/04/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/04/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
29/04/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
29/04/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
29/04/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
29/04/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
29/04/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
29/04/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
17/04/2024
RFRR
REFUSAL PROCESSED BY MPU
16/04/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
28/03/2024
CNRT
NON-FINAL ACTION WRITTEN
27/03/2024
DOCK
ASSIGNED TO EXAMINER
27/03/2024
MAFR
APPLICATION FILING RECEIPT MAILED
19/09/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/09/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
14/09/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PXB-SHIZUKU ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.